Oğuzhan Kurşun
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Oğuzhan Kurşun has a total of 39 co-authors. Here are the top co-authors by number of shared publications:
- Ender Ayvat
Faculty of Physical Therapy and Rehabilitation, Hacettepe University, Ankara, Turkey
2 shared publications - Fatma Ayvat
Faculty of Physical Therapy and Rehabilitation, Hacettepe University, Ankara, Turkey
2 shared publications - Hesna Bektas
Department of Neurology, Ankara Yıldırım Beyazıt University, Ankara, Turkey
2 shared publications - Hulya Karatas
Hacettepe University, Institute of Neurological Sciences and Psychiatry, Ankara, Türkiye
2 shared publications - Muhammed Kılınç
Faculty of Physical Therapy and Rehabilitation, Hacettepe University, Ankara, Turkey
2 shared publications - Serefnur Ozturk
Neurointensive Care Unit Stroke Center Department of Neurology Selcuk University Faculty of Medicine Konya Turkey
2 shared publications
Latest Publications
- Open Access
- 11 July 2026
- Published by MDPI AG in Brain Sciences
- Vol. 16 (7) , 733
Clinical, Laboratory, and CT Morphological Factors Associated with 3-Month Functional Outcomes in Spontaneous Intracerebral Hemorrhage: A Retrospective Cohort Study
Background/Objectives: Spontaneous intracerebral hemorrhage (ICH) is associated with high mortality and disability. We aimed to identify clinical, laboratory, and imaging factors independently associated with 3-month functional outcome across non-contrast computed tomography (NCCT) morphological markers, laboratory biomarkers, and established clinical scoring systems. Methods: This retrospective cohort study included 337 consecutive patients with spontaneous ICH admitted between 2019 and 2022. Admission clinical findings, laboratory parameters, NCCT morphological markers (swirl, blend, black hole, island, hypodensities, and satellite signs), volumetrically segmented hematoma volumes, and prognostic scores (ICH and FUNC scores) were recorded. Poor functional outcome was defined as modified Rankin Scale (mRS) 3–6 at 3 months. Independent predictors were identified using a primary Firth penalized multivariable logistic regression model; discrimination (area under the ROC curve, AUC), calibration, and optimism-corrected performance (1000-resample bootstrap) were assessed, and incremental value over the ICH and FUNC scores was tested with the DeLong method. Results: Poor functional outcome occurred in 60.2% of patients, and 3-month mortality was 36.8%. In the primary penalized model, independent predictors of poor outcome were lower admission Glasgow Coma Scale, larger hematoma volume, NCCT hypodensities, history of hypertension, and lower low-density lipoprotein (LDL) cholesterol. The model showed good discrimination (apparent AUC 0.881; optimism-corrected 0.872) and calibration (slope 0.92) and significantly outperformed the ICH and FUNC scores (DeLong p = 0.009 and p < 0.001, respectively). Several laboratory and treatment variables reached significance only in an unpenalized model and were statistically unstable; these were treated as exploratory. Although swirl, blend, black hole, and island signs were associated with poor outcomes in univariable analysis, they did not remain independent predictors in the final model. The ICH and FUNC scores were significantly associated with poor functional outcome in univariable analysis. Conclusions: Poor 3-month functional outcome after spontaneous ICH is independently associated with neurological severity, hematoma volume, NCCT hypodensities, and selected clinical and laboratory factors. Integrating clinical, volumetric, and CT morphological parameters improved discrimination over established prognostic scores; however, these findings are associative and require prospective, multicenter validation before clinical implementation.
- 11 July 2026
- Published by MDPI AG in Brain Sciences
- Vol. 16 (7) , 733
Open AccessClinical, Laboratory, and CT Morphological Factors Associated with 3-Month Functional Outcomes in Spontaneous Intracerebral Hemorrhage: A Retrospective Cohort Study
Background/Objectives: Spontaneous intracerebral hemorrhage (ICH) is associated with high mortality and disability. We aimed to identify clinical, laboratory, and imaging factors independently associated with 3-month functional outcome across non-contrast computed tomography (NCCT) morphological markers, laboratory biomarkers, and established clinical scoring systems. Methods: This retrospective cohort study included 337 consecutive patients with spontaneous ICH admitted between 2019 and 2022. Admission clinical findings, laboratory parameters, NCCT morphological markers (swirl, blend, black hole, island, hypodensities, and satellite signs), volumetrically segmented hematoma volumes, and prognostic scores (ICH and FUNC scores) were recorded. Poor functional outcome was defined as modified Rankin Scale (mRS) 3–6 at 3 months. Independent predictors were identified using a primary Firth penalized multivariable logistic regression model; discrimination (area under the ROC curve, AUC), calibration, and optimism-corrected performance (1000-resample bootstrap) were assessed, and incremental value over the ICH and FUNC scores was tested with the DeLong method. Results: Poor functional outcome occurred in 60.2% of patients, and 3-month mortality was 36.8%. In the primary penalized model, independent predictors of poor outcome were lower admission Glasgow Coma Scale, larger hematoma volume, NCCT hypodensities, history of hypertension, and lower low-density lipoprotein (LDL) cholesterol. The model showed good discrimination (apparent AUC 0.881; optimism-corrected 0.872) and calibration (slope 0.92) and significantly outperformed the ICH and FUNC scores (DeLong p = 0.009 and p < 0.001, respectively). Several laboratory and treatment variables reached significance only in an unpenalized model and were statistically unstable; these were treated as exploratory. Although swirl, blend, black hole, and island signs were associated with poor outcomes in univariable analysis, they did not remain independent predictors in the final model. The ICH and FUNC scores were significantly associated with poor functional outcome in univariable analysis. Conclusions: Poor 3-month functional outcome after spontaneous ICH is independently associated with neurological severity, hematoma volume, NCCT hypodensities, and selected clinical and laboratory factors. Integrating clinical, volumetric, and CT morphological parameters improved discrimination over established prognostic scores; however, these findings are associative and require prospective, multicenter validation before clinical implementation.
- 26 April 2026
- Published by Elsevier in Archives of Physical Medicine and Rehabilitation
- Vol. 107 (9) , 2468-2480
The Efficacy of Proprioceptive Neuromuscular Facilitation-Based Robot-Assisted Therapy in Individuals With Stroke: A Randomized Controlled Trial
- 26 April 2026
- Published by Elsevier in Archives of Physical Medicine and Rehabilitation
- Vol. 107 (9) , 2468-2480
The Efficacy of Proprioceptive Neuromuscular Facilitation-Based Robot-Assisted Therapy in Individuals With Stroke: A Randomized Controlled Trial
- 1 January 2026
- Published by Turkish Journal of Clinics and Laboratory in TURKISH JOURNAL of CLINICS and LABORATORY
- Vol. 16 (4) , 688-692
ChatGPT 4 may inappropriately answer questions about managing critically ill patients
Intensive care patients have extremely complex pathologies, making their treatment management difficult. In this study, we aim to evaluate ChatGPT 4, a large language model, regarding its knowledge of critically ill patient management. Scenarios involving mechanical ventilation were created by an intensivist, anesthesiologist, and neurologist working in intensive care units, including head trauma, pulmonary embolism, myocardial infarction, chronic obstructive pulmonary disease, chronic kidney disease, and infective endocarditis, septic shock, and status epilepticus. Questions about patient management related to these scenarios were proposed to ChatGPT 4. Although ChatGPT 4 answered most of the questions correctly, it still requires medical input.
- 1 January 2026
- Published by Turkish Journal of Clinics and Laboratory in TURKISH JOURNAL of CLINICS and LABORATORY
- Vol. 16 (4) , 688-692
ChatGPT 4 may inappropriately answer questions about managing critically ill patients
Intensive care patients have extremely complex pathologies, making their treatment management difficult. In this study, we aim to evaluate ChatGPT 4, a large language model, regarding its knowledge of critically ill patient management. Scenarios involving mechanical ventilation were created by an intensivist, anesthesiologist, and neurologist working in intensive care units, including head trauma, pulmonary embolism, myocardial infarction, chronic obstructive pulmonary disease, chronic kidney disease, and infective endocarditis, septic shock, and status epilepticus. Questions about patient management related to these scenarios were proposed to ChatGPT 4. Although ChatGPT 4 answered most of the questions correctly, it still requires medical input.
- 1 January 2024
- Published by Turk Noropsikiyatri Dernegi in Archives of Neuropsychiatry
- Vol. 62 (3) , 256-258
The necessity of vertebral artery Doppler/USG examination in vertigo patients
Vertigo, characterized by a sensation of spinning or movement, presents as a common complaint in primary care, emergency departments, neurology, psychiatry, and otolaryngology clinics. Its diverse etiologies, including inner ear disorders and neurological conditions, pose diagnostic challenges. The diagnostic process typically involves a comprehensive neurological examination, but additional tests like vertebral artery Doppler examination may be necessary, particularly when vascular causes are suspected. However, the necessity of this examination remains unclear. In this retrospective study, we aimed to evaluate the necessity of vertebral artery Doppler/USG examination in patients presenting with vertigo. A cohort of 1021 patients attending a neurology outpatient clinic with complaints of dizziness/vertigo underwent comprehensive evaluation, including vertebral artery ultrasound/Doppler examination. The study revealed that the majority of patients (about 90%) exhibited no evidence of significant vertebral artery atherosclerosis. However, hemodynamically significant vertebral artery pathology was observed in 5.1% of patients, predominantly among older male individuals with cardiovascular risk factors. Additionally, anatomical variations in vertebral artery anatomy were noted, highlighting the importance of considering vascular factors in vertigo evaluation. These findings underscore the importance of tailored diagnostic approaches and comprehensive assessment in patients with vertigo, emphasizing the role of vertebral artery Doppler examination, particularly in specific patient subgroups. Over 60-year-old patients with vertigo are likely to have hemodynamically important vertebral artery atherosclerotic lesions and clinicians should keep this information in mind during daily practice. Understanding the necessity of this adjunctive diagnostic tool can aid in timely diagnosis and management, potentially reducing healthcare costs and optimizing patient outcomes. However, this examination may not be necessary in 90% of vertigo patients.
- 1 January 2024
- Published by Turk Noropsikiyatri Dernegi in Archives of Neuropsychiatry
- Vol. 62 (3) , 256-258
The necessity of vertebral artery Doppler/USG examination in vertigo patients
Vertigo, characterized by a sensation of spinning or movement, presents as a common complaint in primary care, emergency departments, neurology, psychiatry, and otolaryngology clinics. Its diverse etiologies, including inner ear disorders and neurological conditions, pose diagnostic challenges. The diagnostic process typically involves a comprehensive neurological examination, but additional tests like vertebral artery Doppler examination may be necessary, particularly when vascular causes are suspected. However, the necessity of this examination remains unclear. In this retrospective study, we aimed to evaluate the necessity of vertebral artery Doppler/USG examination in patients presenting with vertigo. A cohort of 1021 patients attending a neurology outpatient clinic with complaints of dizziness/vertigo underwent comprehensive evaluation, including vertebral artery ultrasound/Doppler examination. The study revealed that the majority of patients (about 90%) exhibited no evidence of significant vertebral artery atherosclerosis. However, hemodynamically significant vertebral artery pathology was observed in 5.1% of patients, predominantly among older male individuals with cardiovascular risk factors. Additionally, anatomical variations in vertebral artery anatomy were noted, highlighting the importance of considering vascular factors in vertigo evaluation. These findings underscore the importance of tailored diagnostic approaches and comprehensive assessment in patients with vertigo, emphasizing the role of vertebral artery Doppler examination, particularly in specific patient subgroups. Over 60-year-old patients with vertigo are likely to have hemodynamically important vertebral artery atherosclerotic lesions and clinicians should keep this information in mind during daily practice. Understanding the necessity of this adjunctive diagnostic tool can aid in timely diagnosis and management, potentially reducing healthcare costs and optimizing patient outcomes. However, this examination may not be necessary in 90% of vertigo patients.
- Open Access
- 1 December 2023
- Published by Lycia Press London UK in Medical Science and Discovery
- Vol. 10 (12) , 975-979
Comparison of Non-Vitamin K Antagonist Oral Anticoagulants on Ischemic Stroke and Bleeding
Objective: Non-vitamin K antagonist oral anticoagulants (NOACs) have become widely utilized for various clinical indications, including non-valvular atrial fibrillation (NVAF), deep vein thrombosis (DVT), and apical thrombus. Despite their increasing popularity, limited comparative data exist on the clinical outcomes associated with different NOACs. This study aims to address this gap by directly comparing NOACs in terms of ischemic stroke, hemorrhagic stroke, and gastrointestinal bleeding. Materials and Methods: A retrospective search of the electronic database was conducted to identify patients using NOACs for NVAF, DVT, and apical thrombus. Clinical outcomes, including ischemic stroke, hemorrhagic stroke, and gastrointestinal bleeding, were directly compared among different NOACs. The chi-square test and Fisher's exact test were employed to assess the relative incidence of stroke and extracranial complications across four patient groups. Results: Among the 4,112 retrospectively analyzed patients, 55 were included in the study. Demographic and clinical profiles showed no significant differences among patients in the four different drug groups (p > 0.05). Ischemic stroke was observed in 90.9% of the patients, hemorrhagic stroke in 5.8%, and gastrointestinal bleeding in 3.3%. A statistically significant difference was identified between drug doses and the rate of ischemic stroke (p < 0.001). Conclusion: The findings of this retrospective study carry significant implications, especially considering the widespread global use of NOACs. The study revealed no discernible difference in the risk of ischemic stroke among patients using different NOACs. Notably, the risk of hemorrhagic stroke was dose-dependent in the dabigatran group, while rivaroxaban was associated with the highest risk of gastrointestinal bleeding. Given the elevated rate of thromboembolism in patients and the relatively short half-life of NOACs, the study concludes that further optimization of NOAC use is imperative.
- 1 December 2023
- Published by Lycia Press London UK in Medical Science and Discovery
- Vol. 10 (12) , 975-979
Open AccessComparison of Non-Vitamin K Antagonist Oral Anticoagulants on Ischemic Stroke and Bleeding
Objective: Non-vitamin K antagonist oral anticoagulants (NOACs) have become widely utilized for various clinical indications, including non-valvular atrial fibrillation (NVAF), deep vein thrombosis (DVT), and apical thrombus. Despite their increasing popularity, limited comparative data exist on the clinical outcomes associated with different NOACs. This study aims to address this gap by directly comparing NOACs in terms of ischemic stroke, hemorrhagic stroke, and gastrointestinal bleeding. Materials and Methods: A retrospective search of the electronic database was conducted to identify patients using NOACs for NVAF, DVT, and apical thrombus. Clinical outcomes, including ischemic stroke, hemorrhagic stroke, and gastrointestinal bleeding, were directly compared among different NOACs. The chi-square test and Fisher's exact test were employed to assess the relative incidence of stroke and extracranial complications across four patient groups. Results: Among the 4,112 retrospectively analyzed patients, 55 were included in the study. Demographic and clinical profiles showed no significant differences among patients in the four different drug groups (p > 0.05). Ischemic stroke was observed in 90.9% of the patients, hemorrhagic stroke in 5.8%, and gastrointestinal bleeding in 3.3%. A statistically significant difference was identified between drug doses and the rate of ischemic stroke (p < 0.001). Conclusion: The findings of this retrospective study carry significant implications, especially considering the widespread global use of NOACs. The study revealed no discernible difference in the risk of ischemic stroke among patients using different NOACs. Notably, the risk of hemorrhagic stroke was dose-dependent in the dabigatran group, while rivaroxaban was associated with the highest risk of gastrointestinal bleeding. Given the elevated rate of thromboembolism in patients and the relatively short half-life of NOACs, the study concludes that further optimization of NOAC use is imperative.
- 7 October 2023
- Published by Medknow in Neurological Sciences and Neurophysiology
- Vol. 40 (4) , 200-206
Transcranial Sonography in Parkinson’s Disease and Parkinsonism
Background: Transcranial sonography (TCS) is a noninvasive imaging method that practices ultrasound waves to examine the brain structure changes in many neurological pathologies, including Parkinson’s disease (PD) and parkinsonism. It allows for the visualization of the substantia nigra (SN), which is affected in these conditions and other brain parts. This technique has shown promise in aiding the diagnosis, follow-up, and progress of PD, in addition to differentiating it from other movement disorders. Our research explores the reliability of TCS in the diagnosis of PD and its impact on the differential diagnosis of atypical parkinsonism syndromes. Subjects and Methods: This study involved 52 PD patients, nine with other parkinsonism, and 54 healthy people. The same neurosonologist, blind to the patient’s diagnosis, assessed each individual’s SN, and the hyperechogenic area measurement was obtained. These measurements were compared between PD patients, with other forms of PD, and healthy people. In addition, hyperechogenic regions were compared based on the PD subtypes, dominant disease side, severity, and duration of the disease. Results: PD patients were presented with the highest value of SN hyperechogenic regions. TCS had an 87.5% specificity and a 73.3% sensitivity rate for the diagnosis of PD. The akinetic-rigid subtype of PD showed higher hyperechogenicity. In PD patients, there was no correlation between the disease side, length of the disease, Hoehn and Yahr stage, and SN hyperechogenicity. Conclusion: The results of this research demonstrate that the visualizing of SN hyperechogenicity with TCS in PD has diagnostic significance and may be valuable in the differential diagnosis of atypical parkinsonism disorders. However, the evaluation of only the SN may not be sufficient to advantage from TCS in the diagnosis of other parkinsonisms, and it may be essential to investigate the mesencephalon, other basal ganglia, and the third ventricle.
- 7 October 2023
- Published by Medknow in Neurological Sciences and Neurophysiology
- Vol. 40 (4) , 200-206
Transcranial Sonography in Parkinson’s Disease and Parkinsonism
Background: Transcranial sonography (TCS) is a noninvasive imaging method that practices ultrasound waves to examine the brain structure changes in many neurological pathologies, including Parkinson’s disease (PD) and parkinsonism. It allows for the visualization of the substantia nigra (SN), which is affected in these conditions and other brain parts. This technique has shown promise in aiding the diagnosis, follow-up, and progress of PD, in addition to differentiating it from other movement disorders. Our research explores the reliability of TCS in the diagnosis of PD and its impact on the differential diagnosis of atypical parkinsonism syndromes. Subjects and Methods: This study involved 52 PD patients, nine with other parkinsonism, and 54 healthy people. The same neurosonologist, blind to the patient’s diagnosis, assessed each individual’s SN, and the hyperechogenic area measurement was obtained. These measurements were compared between PD patients, with other forms of PD, and healthy people. In addition, hyperechogenic regions were compared based on the PD subtypes, dominant disease side, severity, and duration of the disease. Results: PD patients were presented with the highest value of SN hyperechogenic regions. TCS had an 87.5% specificity and a 73.3% sensitivity rate for the diagnosis of PD. The akinetic-rigid subtype of PD showed higher hyperechogenicity. In PD patients, there was no correlation between the disease side, length of the disease, Hoehn and Yahr stage, and SN hyperechogenicity. Conclusion: The results of this research demonstrate that the visualizing of SN hyperechogenicity with TCS in PD has diagnostic significance and may be valuable in the differential diagnosis of atypical parkinsonism disorders. However, the evaluation of only the SN may not be sufficient to advantage from TCS in the diagnosis of other parkinsonisms, and it may be essential to investigate the mesencephalon, other basal ganglia, and the third ventricle.
- 1 February 2022
- Published by Bentham Science Publishers Ltd. in CNS & Neurological Disorders - Drug Targets
- Vol. 21 (2) , 150-159
Arachidonic Acid Metabolites in Neurologic Disorders
Background & Objective: Arachidonic acid (ARA) is essential for the fluidity, selective permeability, and flexibility of the cell membrane. It is an important factor for the function of all cells, particularly in the nervous system, immune system, and vascular endothelium. ARA is the second most common polyunsaturated fatty acid in the phospholipids of the nerve cell membrane after docosahexaenoic acid. ARA metabolites have many kinds of physiologic roles. The major action of ARA metabolites is the promotion of the acute inflammatory response, mediated by the production of pro-inflammatory mediators such as PGE2 and PGI2, followed by the formation of lipid mediators, which have pro-resolving effects. Another important action of ARA derivatives, especially COX, is the regulation of vascular reactivity through PGs and TXA2. There is significant involvement of ARA metabolites in neurodegenerative diseases, including Alzheimer’s disease, Parkinson’s disease, amyotrophic lateral sclerosis, and neuropsychiatric disorders. ARA derivatives also make an important contribution to acute stroke, global ischemia, subarachnoid hemorrhage, and anticoagulation-related hemorrhagic transformation.Conclusion: In this review, we have discussed experimental and human study results of neurologic disorders related to ARA and its metabolites in line with treatment options.
- 1 February 2022
- Published by Bentham Science Publishers Ltd. in CNS & Neurological Disorders - Drug Targets
- Vol. 21 (2) , 150-159
Arachidonic Acid Metabolites in Neurologic Disorders
Background & Objective: Arachidonic acid (ARA) is essential for the fluidity, selective permeability, and flexibility of the cell membrane. It is an important factor for the function of all cells, particularly in the nervous system, immune system, and vascular endothelium. ARA is the second most common polyunsaturated fatty acid in the phospholipids of the nerve cell membrane after docosahexaenoic acid. ARA metabolites have many kinds of physiologic roles. The major action of ARA metabolites is the promotion of the acute inflammatory response, mediated by the production of pro-inflammatory mediators such as PGE2 and PGI2, followed by the formation of lipid mediators, which have pro-resolving effects. Another important action of ARA derivatives, especially COX, is the regulation of vascular reactivity through PGs and TXA2. There is significant involvement of ARA metabolites in neurodegenerative diseases, including Alzheimer’s disease, Parkinson’s disease, amyotrophic lateral sclerosis, and neuropsychiatric disorders. ARA derivatives also make an important contribution to acute stroke, global ischemia, subarachnoid hemorrhage, and anticoagulation-related hemorrhagic transformation.Conclusion: In this review, we have discussed experimental and human study results of neurologic disorders related to ARA and its metabolites in line with treatment options.
- 1 January 2022
- Published by Turk Noropsikiyatri Dernegi in Archives of Neuropsychiatry
- Vol. 60 (2) , 117-123
COMPARISON OF OPTIC NERVE SHEATH DIAMETERS MEASURED BY OPTIC ULTRASONOGRAPHY BEFORE AND AFTER LUMBAR PUNCTURE IN IDIOPATHIC INTRACRANIAL HYPERTENSION PATIENTS
Idiopathic intracranial hypertension (IIH) symptoms include headache, blurred vision, and papilledema which may lead to permanent vision loss unless diagnosed and treated. Definitive diagnosis of IIH usually requires the measurement of intracranial pressure (ICP) via lumbar puncture (LP) which is an invasive and unwanted technique for patients. In our study, optic nerve sheath diameters (ONSD) were measured before and after lumbar puncture in IIH patients and the relationship of these measurements with ICP changes was evaluated as well as the effect of decreasing cerebrospinal fluid (CSF) pressure after a lumbar puncture on ONSD. Thus, we want to investigate whether optic nerve ultrasonography (USG) is a useful tool instead of the invasive LP for the diagnosis of IIH. A total of 25 patients who applied to the neurology clinics of Ankara Numune Training and Research Hospital between May 2014 and December 2015 and were diagnosed with IIH were included in the study. The control group consisted of 22 individuals who applied with complaints other than headaches, visual impairment or tinnitus. Optic nerve sheath diameters were measured from both eyes before and after the LP. After pre-LP measurements were taken, opening and closing CSF pressure was measured. In the control group, ONSD was measured with optic USG. Mean age of the IIH group and the control group was determined as 34.8±11.5 and 45.8±13.3 years, respectively. In the patient group, mean CSF opening pressure was 33.9±8.0 cm H2O and mean closing pressure was 18.1±4.7 cm H2O. Mean ONSD measured pre-LP was 7.1±1.0 mm in the right eye and 6.9±0.7 mm in the left eye, while mean post-LP ONSD was 6.7±0.9 mm in the right eye and 6.4±0.8 mm in the left eye. There was a statistically significant difference between ONSD values before and after the LP (p=0.006 for the right eye, p<0.001 for the left eye). In the control group, mean ONSD was 5.4±0.7 mm in the right eye and 5.5±0.6 mm in the left eye, and a statistically significant difference was found between ONSD values before and after the LP (p<0.001 for the right eye and left eye). A significant positive correlation was determined between left ONSD measurements before the LP and CSF opening pressure (r=0.501, p=0.011). In the present study, it was found that ONSD measurement by optic USG significantly displays increased ICP, and decreasing pressure via LP is rapidly reflecting ONSD measurement. Based on these findings, it is suggested that ONSD measurements by optic USG, a non-invasive method, can be used in the diagnosis and follow-up of IIH patients.
- 1 January 2022
- Published by Turk Noropsikiyatri Dernegi in Archives of Neuropsychiatry
- Vol. 60 (2) , 117-123
COMPARISON OF OPTIC NERVE SHEATH DIAMETERS MEASURED BY OPTIC ULTRASONOGRAPHY BEFORE AND AFTER LUMBAR PUNCTURE IN IDIOPATHIC INTRACRANIAL HYPERTENSION PATIENTS
Idiopathic intracranial hypertension (IIH) symptoms include headache, blurred vision, and papilledema which may lead to permanent vision loss unless diagnosed and treated. Definitive diagnosis of IIH usually requires the measurement of intracranial pressure (ICP) via lumbar puncture (LP) which is an invasive and unwanted technique for patients. In our study, optic nerve sheath diameters (ONSD) were measured before and after lumbar puncture in IIH patients and the relationship of these measurements with ICP changes was evaluated as well as the effect of decreasing cerebrospinal fluid (CSF) pressure after a lumbar puncture on ONSD. Thus, we want to investigate whether optic nerve ultrasonography (USG) is a useful tool instead of the invasive LP for the diagnosis of IIH. A total of 25 patients who applied to the neurology clinics of Ankara Numune Training and Research Hospital between May 2014 and December 2015 and were diagnosed with IIH were included in the study. The control group consisted of 22 individuals who applied with complaints other than headaches, visual impairment or tinnitus. Optic nerve sheath diameters were measured from both eyes before and after the LP. After pre-LP measurements were taken, opening and closing CSF pressure was measured. In the control group, ONSD was measured with optic USG. Mean age of the IIH group and the control group was determined as 34.8±11.5 and 45.8±13.3 years, respectively. In the patient group, mean CSF opening pressure was 33.9±8.0 cm H2O and mean closing pressure was 18.1±4.7 cm H2O. Mean ONSD measured pre-LP was 7.1±1.0 mm in the right eye and 6.9±0.7 mm in the left eye, while mean post-LP ONSD was 6.7±0.9 mm in the right eye and 6.4±0.8 mm in the left eye. There was a statistically significant difference between ONSD values before and after the LP (p=0.006 for the right eye, p<0.001 for the left eye). In the control group, mean ONSD was 5.4±0.7 mm in the right eye and 5.5±0.6 mm in the left eye, and a statistically significant difference was found between ONSD values before and after the LP (p<0.001 for the right eye and left eye). A significant positive correlation was determined between left ONSD measurements before the LP and CSF opening pressure (r=0.501, p=0.011). In the present study, it was found that ONSD measurement by optic USG significantly displays increased ICP, and decreasing pressure via LP is rapidly reflecting ONSD measurement. Based on these findings, it is suggested that ONSD measurements by optic USG, a non-invasive method, can be used in the diagnosis and follow-up of IIH patients.
- Top Cited PapersOpen Access
- 10 June 2021
- Published by Springer Nature in The Journal of Headache and Pain
- Vol. 22 (1) , 1-13
Migraine and neuroinflammation: the inflammasome perspective
Background: Neuroinflammation has an important role in the pathophysiology of migraine, which is a complex neuro-glio-vascular disorder. The main aim of this review is to highlight findings of cortical spreading depolarization (CSD)-induced neuroinflammatory signaling in brain parenchyma from the inflammasome perspective. In addition, we discuss the limited data of the contribution of inflammasomes to other aspects of migraine pathophysiology, foremost the activation of the trigeminovascular system and thereby the generation of migraine pain.Main body: Inflammasomes are signaling multiprotein complexes and key components of the innate immune system. Their activation causes the production of inflammatory cytokines that can stimulate trigeminal neurons and are thus relevant to the generation of migraine pain. The contribution of inflammasome activation to pain signaling has attracted considerable attention in recent years. Nucleotide-binding domain (NOD)-like receptor family pyrin domain containing 3 (NLRP3) is the best characterized inflammasome and there is emerging evidence of its role in a variety of inflammatory pain conditions, including migraine. In this review, we discuss, from an inflammasome point of view, cortical spreading depolarization (CSD)-induced neuroinflammatory signaling in brain parenchyma, the connection with genetic factors that make the brain vulnerable to CSD, and the relation of the inflammasome with diseases that are co-morbid with migraine, including stroke, epilepsy, and the possible links with COVID-19 infection.Conclusion: Neuroinflammatory pathways, specifically those involving inflammasome proteins, seem promising candidates as treatment targets, and perhaps even biomarkers, in migraine.
- 10 June 2021
- Published by Springer Nature in The Journal of Headache and Pain
- Vol. 22 (1) , 1-13
Top Cited PapersOpen AccessMigraine and neuroinflammation: the inflammasome perspective
Background: Neuroinflammation has an important role in the pathophysiology of migraine, which is a complex neuro-glio-vascular disorder. The main aim of this review is to highlight findings of cortical spreading depolarization (CSD)-induced neuroinflammatory signaling in brain parenchyma from the inflammasome perspective. In addition, we discuss the limited data of the contribution of inflammasomes to other aspects of migraine pathophysiology, foremost the activation of the trigeminovascular system and thereby the generation of migraine pain.Main body: Inflammasomes are signaling multiprotein complexes and key components of the innate immune system. Their activation causes the production of inflammatory cytokines that can stimulate trigeminal neurons and are thus relevant to the generation of migraine pain. The contribution of inflammasome activation to pain signaling has attracted considerable attention in recent years. Nucleotide-binding domain (NOD)-like receptor family pyrin domain containing 3 (NLRP3) is the best characterized inflammasome and there is emerging evidence of its role in a variety of inflammatory pain conditions, including migraine. In this review, we discuss, from an inflammasome point of view, cortical spreading depolarization (CSD)-induced neuroinflammatory signaling in brain parenchyma, the connection with genetic factors that make the brain vulnerable to CSD, and the relation of the inflammasome with diseases that are co-morbid with migraine, including stroke, epilepsy, and the possible links with COVID-19 infection.Conclusion: Neuroinflammatory pathways, specifically those involving inflammasome proteins, seem promising candidates as treatment targets, and perhaps even biomarkers, in migraine.
- 11 May 2021
- Published by Springer Nature in The Cerebellum
- Vol. 21 (1) , 64-72
The Effects of Exergame on Postural Control in Individuals with Ataxia: a Rater-Blinded, Randomized Controlled, Cross-over Study
Exergame trainings might have therapeutic value in ataxic patients. The aim of this study was to investigate the effect of exergame training with an exercise program on postural control by comparing it with traditional balance and coordination exercise program. Nineteen patients were randomly allocated to two groups. In the first group, exergame training and an exercise program (EEP) were applied together for the first 8 weeks; after 10 weeks washout, a conventional exercise program (CEP) was applied for the second 8 weeks. In the second group, the CEP was applied first followed by the EEP. Outcome measures were Limits of Stability test (LoS), International Classification Ataxia Ratio Scale (ICARS), Berg Balance Scale (BBS), and Timed-Up and Go test with a cognitive task (TUG-C), Reactive postural control and sensory orientation subscales of the Mini-BESTest. Seventeen patients (mean age ± SD, 32.53 ± 11.07 years) completed the study. ICARS, BBS scores improved only after EEP (p < 0.05). While there was no change in the RT and MVL parameters of the LoS test after EEP, the MXE, EPE, and DCL parameters improved significantly (p < 0.05). The MXE and MVL parameters of LoS improved after CEP (p < 0.05). There were no significant improvements in the Mini-BESTest’s reactive postural control and sensory orientation subscale scores after both EEP and CEP (p > 0.05). The results of the present study demonstrated that exergame training can be used as a complementary training option in physiotherapy to improve postural control in patients with ataxia. ClinicalTrial.gov Identifier: NCT03607058
- 11 May 2021
- Published by Springer Nature in The Cerebellum
- Vol. 21 (1) , 64-72
The Effects of Exergame on Postural Control in Individuals with Ataxia: a Rater-Blinded, Randomized Controlled, Cross-over Study
Exergame trainings might have therapeutic value in ataxic patients. The aim of this study was to investigate the effect of exergame training with an exercise program on postural control by comparing it with traditional balance and coordination exercise program. Nineteen patients were randomly allocated to two groups. In the first group, exergame training and an exercise program (EEP) were applied together for the first 8 weeks; after 10 weeks washout, a conventional exercise program (CEP) was applied for the second 8 weeks. In the second group, the CEP was applied first followed by the EEP. Outcome measures were Limits of Stability test (LoS), International Classification Ataxia Ratio Scale (ICARS), Berg Balance Scale (BBS), and Timed-Up and Go test with a cognitive task (TUG-C), Reactive postural control and sensory orientation subscales of the Mini-BESTest. Seventeen patients (mean age ± SD, 32.53 ± 11.07 years) completed the study. ICARS, BBS scores improved only after EEP (p < 0.05). While there was no change in the RT and MVL parameters of the LoS test after EEP, the MXE, EPE, and DCL parameters improved significantly (p < 0.05). The MXE and MVL parameters of LoS improved after CEP (p < 0.05). There were no significant improvements in the Mini-BESTest’s reactive postural control and sensory orientation subscale scores after both EEP and CEP (p > 0.05). The results of the present study demonstrated that exergame training can be used as a complementary training option in physiotherapy to improve postural control in patients with ataxia. ClinicalTrial.gov Identifier: NCT03607058